TITLE

Presence of Multiple Genotype-Specific Antibodies in Patients With Persistent Infection With Hepatitis C Virus (HCV) of a Single Genotype: Evidence for Transient or Occult Superinfection With HCV of Different Genotypes

AUTHOR(S)
Toyoda, Hidenori; Fukuda, Yoshihide; Hayakawa, Tetsuo; Kumada, Takashi; Nakano, Satoshi; Takamatsu, Junki; Saito, Hidehiko
PUB. DATE
August 1999
SOURCE
American Journal of Gastroenterology;Aug1999, Vol. 94 Issue 8, p2230
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
OBJECTIVE: We investigated the significance of multiple genotype- specific antibodies in patients with persistent infection with hepatitis C virus (HCV) of a single genotype. METHODS: Titers of genotype-specific antibodies to group 1 and 2 HCV polypeptides in the NS4 region of HCV were measured in 53 hemophiliacs and 58 nonhemophiliacs who were persistently infected with HCV of a single genotype. In addition, sequence variability in hypervariable region 1 (HVR1) of HCV was evaluated in these patients. RESULTS: The presence of antibodies to both group 1 and 2 polypeptides, reflecting a mixture of serotypes, was more frequent in hemophiliacs (11 of 53 patients, 20.8%) than in nonhemophiliacs (two of 58 patients, 3.4%; p = 0.01), HVR1 sequence variability in 13 patients with mixed sero-types was higher than in 87 patients with a single serotype (21.1 ± 4.3% vs 8.5 ± 6.3%; p < 0.01), CONCLUSIONS: A mixture of HCV serotypes was more common in hemophiliacs with persistent HCV infection of a single genotype who were at high risk of exposure to HCV than in nonhemophiliacs, and the sequence variability of the infecting strains was high in these patients. These data are suggestive of the effects of superinfection with HCV of different genotypes. The presence of multiple genotype-specific antibodies to HCV may be evidence of transient or occult superinfection with HCV of different genotypes in patients with persistent infection by HCV of a single genotype.
ACCESSION #
17830926

 

Related Articles

  • Hepatitis C virus genotypes in injecting drug users from Romania. Sultana, Camelia; Vagu, Codruta; Temereanca, Aura; Grancea, Camelia; Slobozeanu, Josefina; Ruta, Simona // Central European Journal of Medicine;Oct2011, Vol. 6 Issue 5, p672 

    Due to the increasing number of infections related to injecting drug use, both the pattern of hepatitis C virus (HCV) transmission, and the circulating genotypes in Europe have changed. As there are little available data in this respect for Romania, the aim of our study was a preliminary...

  • Perinatal Transmission of Hepatitis G Virus (GB Virus Type C) and Hepatitis C Virus Infections--A Comparison. Wejstål, Rune; Månson, Ann-Sofie; Widell, Anders; Norkrans, Gunnar // Clinical Infectious Diseases;4/1/1999, Vol. 28 Issue 4, p816 

    Focuses on a study which analyzed the prevalences of hepatits G virus and hepatitis C virus viremia among mothers and their newborns and tested the mothers for antibody to hepatitis G virus. Patients and methods; Results; Discussion.

  • Home test for hepatitis C.  // WHO Drug Information;1999, Vol. 13 Issue 2, p94 

    Reports on the approval of the first over-the-counter blood collection kit to test for antibodies to hepatitis C virus (HCV) in the U.S. Provision of a telemedicine service; Education and counselling about HCV; Influence of HCV in causing liver damage.

  • The Prevalence of Hepatitis C Virus Antibodies among Hemodialysis Patients. Zeldis, Jerome B.; Depner, Thomas A.; Kuramoto, I.K.; Gish, Robert G.; Holland, Paul V. // Annals of Internal Medicine;6/15/90, Vol. 112 Issue 12, p958 

    Deals with a study which examined the prevalence of anti-hepatitis C virus (HCV) antibodies and the factors that predispose patients to have antibody to HCV. Methods; Results; Discussion.

  • Molecular epidemiology of hepatitis C among drug users in Flanders, Belgium: association of genotype with clinical parameters and with sex- and drug-related risk behaviours. Matheï, C.; Wollants, E.; Verbeeck, J.; van Ranst, M.; Robaeys, G.; van Damme, P.; Buntinx, F. // European Journal of Clinical Microbiology & Infectious Diseases;Aug2005, Vol. 24 Issue 8, p514 

    The aim of this study was to determine the genotypic variation of hepatitis C among drug users in Flanders and to relate the distribution of genotypes to the characteristics of the population. Hepatitis C virus RNA (HCV-RNA) quantification and genotyping was performed on stored samples from 161...

  • Prospective study of hepatitis C virus infection in hemodialysis patients by monthly analysis of HCV RNA and antibodies. Moreira, Regina; Pinho, Jo�o Renato Rebello; Fares, Jorge; Oba, Isabel Takano; Cardoso, Maria Regina; Saraceni, Cl�udia Patara; Granato, Celso // Canadian Journal of Microbiology;Aug2003, Vol. 49 Issue 8, p503 

    The aims of this study were to (i) evaluate the prevalence and the incidence of hepatitis C virus (HCV) infection in hemodialysis patients in two different centers in S�o Paulo (Brazil), (ii) determine the time required to detect HCV infection among these patients by serology or PCR, (iii)...

  • Outcome of Intravenous Immunoglobulin-Transmitted HTLV-I, Hepatitis B, Hepatitis C, and HIV infections. Foroughipour, Mohsen; Jabbari Azad, Farahzad; Farid hosseini, Reza; Shirdel, Abbas; Reza Khalighi, Amir; Yousefzadeh, Hadis; Sadri, Homa; Moghiman, Toktam; Hekmatkhah, Hossein // Iranian Journal of Basic Medical Sciences;Mar2013, Vol. 16 Issue 3, p228 

    Objective(s): Since each unit of Intravenous Immunoglobulin (IVIG) is obtained from different blood donors, blood-borne viral diseases is of high importance. We aimed at investigating the prevalence of various viral infections: Human T-cell Lymphotropic Virus Type 1 (HTLV-I), Hepatitis B (HBV),...

  • Improving the Diagnosis of Acute Hepatitis C Virus Infection with Expanded Viral Load Criteria. McGovern, Barbara H.; Birch, Christopher E.; Bowen, Melinda J.; Reyor, Laura L.; Nagami, Ellen H.; Chung, Raymond T.; Kim, Arthur Y. // Clinical Infectious Diseases;10/1/2009, Vol. 49 Issue 7, p1051 

    Background. The diagnosis of acute hepatitis C virus (HCV) infection is imprecise because antibody testing does not differentiate between acute and chronic infection. Although virologic features, such as viral load fluctuations and low levels of viremia, have been noted to be characteristic of...

  • Protective Immunity against Hepatitis C: Many Shades of Grey. Abdel-Hakeem, Mohamed S.; Shoukry, Naglaa H. // Frontiers in Immunology;May2014, Vol. 5, preceding p1 

    The majority of individuals who become acutely infected with hepatitis C virus (HCV) develop chronic infection and suffer from progressive liver damage while approximately 25% are able to eliminate the virus spontaneously. Despite the recent introduction of new direct-acting antivirals (DAAs),...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics